Evidence map›Paper›PMID 36012773›Full record

ArticleJournal of fungi (Basel, Switzerland)2022

Evaluation of Anti-

Claudia Patrícia Bravo-Chaucanés, Yerly Vargas-Casanova, Luis Carlos Chitiva-Chitiva, Andrés Ceballos-Garzon, Geison Modesti-Costa, Claudia Marcela Parra-Giraldo

Open access · goldAbstract read
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Frontiers in fungal biology · 2026
    Article
  4. Review
  5. Chemical Composition, Biocompatibility, and Anti-Pathogens (Basel, Switzerland) · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Evaluating theACS omega · 2023
    Article
  11. Article
  12. Article
  13. Anti-Journal of fungi (Basel, Switzerland) · 2023
    Article
  14. A semi purified hydroalcoholic fraction fromFrontiers in pharmacology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Claudia Patrícia Bravo-ChaucanésUnidad de Proteómica y Micosis Humanas, Grupo de Enfermedades Infecciosas, Departamento de Microbiología, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá 110231, DC, Colombia.
Yerly Vargas-CasanovaUnidad de Proteómica y Micosis Humanas, Grupo de Enfermedades Infecciosas, Departamento de Microbiología, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá 110231, DC, Colombia.
Luis Carlos Chitiva-ChitivaGrupo de Investigación Fitoquímica Universidad Javeriana (GIFUJ), Departamento de Química, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá 110231, DC, Colombia.ORCID 0000-0003-1422-5545
Andrés Ceballos-GarzonUnidad de Proteómica y Micosis Humanas, Grupo de Enfermedades Infecciosas, Departamento de Microbiología, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá 110231, DC, Colombia.ORCID 0000-0002-0743-6857
Geison Modesti-CostaGrupo de Investigación Fitoquímica Universidad Javeriana (GIFUJ), Departamento de Química, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá 110231, DC, Colombia.ORCID 0000-0003-2449-1986
Claudia Marcela Parra-GiraldoUnidad de Proteómica y Micosis Humanas, Grupo de Enfermedades Infecciosas, Departamento de Microbiología, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá 110231, DC, Colombia.ORCID 0000-0003-1302-5429
Pontificia Universidad Javeriana · COUniversité Clermont Auvergne · FR

Funding

Becas de Excelencia Doctoral del Bicentenario 2019Call Scientific Ecosystem for I+D+i 792-2017Minciencias 848-2019Pontificia Universidad Javeriana 08711-20World Bank and the Vice Presidency of Research at Pontificia Universidad Javeriana FP44842-221-2018
6 · The paper itself

Abstract

Due to the increased incidence of fungal infections and the emergence of antifungal resistance mainly by

Indexed as

antibiofilmCandida albicansC. aurisenzyme activitymorphogenesisPiper nigrumtoxicity

Identifiers

PMID36012773
PMCPMC9409899
OpenAlexW4288077771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.